Royalty Pharma Plc (RPRX) reported its Q4 2024 earnings today, revealing earnings per share (EPS) of $0.3531, falling short of the forecasted $0.9849. The company also reported revenue of $594 million ...
Podcasts’ role in the 2024 campaign, during which Donald Trump sat down for free-wheeling conversations with the most popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback